Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2025-12-25 @ 2:18 AM
NCT ID: NCT03349034
Eligibility Criteria: Inclusion Criteria: * Patients receiving osseocutaneous free tissue transfer regardless of the indication for free tissue transfer. This includes osseocutaneous tissue from fibula and scapula * Age ≥ 18 Exclusion Criteria: * Patients unable to understand the research protocol and/or provide informed consent * Patients under the age of 18 * Patients with a history of allergic reaction to Ropivacaine or other local amide anesthetics * Patients whose participation in this trial would require exclusion from participation in another clinical research trial related to the patient's malignant diagnosis. * Patients with previous pain disorders or drug abuse requiring chronic narcotic use. * Vulnerable populations (adults unable to consent, individuals who are not yet adults, wards of the state, prisoners)
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT03349034
Study Brief:
Protocol Section: NCT03349034